Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial

Yalcin, S.Uslu, R.Dane, F.Yilmaz, U.Zengin, N.Buyukunal, E.Buyukberber, S.Camci, C.Sencan, O.Kilickap, S.2019-10-272019-10-2720110732-183X1527-7755https://doi.org/10.1200/jco.2011.29.15_suppl.3579https://hdl.handle.net/11454/44459en10.1200/jco.2011.29.15_suppl.3579info:eu-repo/semantics/closedAccessBevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trialConference Object2915WOS:000208880300353Q1